4//SEC Filing
Sibold William John 4
Accession 0001518611-25-000007
CIK 0001157601other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 5:44 PM ET
Size
7.1 KB
Accession
0001518611-25-000007
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-08-21$400.03/sh−6,485$2,594,225→ 110,884 total - Sale
Common Stock
2025-08-21$401.00/sh−1,131$453,531→ 109,753 total
Footnotes (3)
- [F1]These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.00 to $400.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnote below.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.00 to $401.01, inclusive.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001518611
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 5:44 PM ET
- Size
- 7.1 KB